Wujin Chen
Fuzhou, 350122, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Targeting Tumor-Associated Macrophages to Reshape the Immuno-Mechanical Landscape: Molecular Mechanisms and Therapeutic Strategies.
Journal: International journal of biological sciences
Published: February 01, 2026
Correction: Qingjie Fuzheng granules attenuate cancer cachexia by restoring gut microbiota homeostasis and suppressing IL-6/NF-κB signaling in colorectal adenocarcinoma.
Journal: Hereditas
Published: September 17, 2025
Diabetes as an independent risk factor for severe inflammatory bowel disease: evidence from an inflammation-metabolism-liver coupling framework.
Journal: Frontiers in endocrinology
Published: September 17, 2025
Qingxie Fuzheng granules attenuate cancer cachexia by restoring gut microbiota homeostasis and suppressing IL-6/NF-κB signaling in colorectal adenocarcinoma.
Journal: Hereditas
Published: July 18, 2025
Chronic Psychological Stress in Oncogenesis: Multisystem Crosstalk and Multimodal Interventions.
Journal: Research (Washington, D.C.)
Published: July 18, 2025
Baicalin Inhibits Lung Cancer Cell Proliferation and Migration via ALOX12-Mediated Ferroptosis.
Journal: Anti-cancer agents in medicinal chemistry
Published: November 19, 2024
Paeonol alleviates ulcerative colitis by modulating PPAR-γ and nuclear factor-κB activation.
Journal: Scientific reports
Published: January 08, 2024
Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer.
Journal: Frontiers in oncology
Published: January 07, 2022
Identification of mini-chromosome maintenance 8 as a potential prognostic marker and its effects on proliferation and apoptosis in gastric cancer.
Journal: Journal of cellular and molecular medicine
Published: July 18, 2020
Apatinib plus Chemotherapy as a Second-Line Treatment in Unresectable Non-Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical Trial.
Journal: The oncologist
Published: May 30, 2020
Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.
Journal: Anti-cancer agents in medicinal chemistry
Published: May 23, 2020
Effects and Mechanisms of Anlotinib and Dihydroartemisinin Combination Therapy in Ameliorating Malignant Biological Behavior of Gastric Cancer Cells.
Journal: Current pharmaceutical biotechnology
Published: February 19, 2020
Last Updated: 09/26/2026